Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06542835 · ClinicalTrials.gov registry record · NA
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity
A NA study of Colorectal Cancer, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 6,000
- Enrollment target
- 1
- Study location
NCT06542835: Recruiting NA study of Colorectal Cancer, sponsored by University of Arizona.
NCT06542835 is a NA study of Colorectal Cancer that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 6,000 participants, above the 1,529-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (292% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06542835, a NA study of Colorectal Cancer, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 6,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.
Primary Outcome
Measure the completion rate of colorectal cancer (CRC) screening at the individual level within 6 months of receiving the intervention. This will compare the proportion of participants in the post-intervention group versus the pre-intervention group.
Conditions Studied
Interventions
- BEHAVIORAL Video text message
- BEHAVIORAL In-clinic CRC screening promotion
- BEHAVIORAL Mailed FIT
- BEHAVIORAL Social needs navigation
- BEHAVIORAL Reminders
Study Locations (1)
California
- AltaMed Health Services Corporation - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2024-07-31 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT06542835 shows while recruiting
NCT06542835 is an interventional study that assigns participants to a tested intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,529-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (292% higher).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 5 interventions - of which Video text message is the first listed.
NCT06542835 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06542835 about?
NCT06542835 is a clinical study titled "Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity". Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.
What is the current status of trial NCT06542835?
This trial is currently recruiting. It is a NA study. The enrollment target is 6,000 participants. The study started on 2024-07-31. Estimated completion is 2027-01.
What conditions does trial NCT06542835 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT06542835?
The interventions under investigation include: Video text message (BEHAVIORAL), In-clinic CRC screening promotion (BEHAVIORAL), Mailed FIT (BEHAVIORAL), Social needs navigation (BEHAVIORAL), Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT06542835?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06542835 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06542835's enrollment target sits among peer trials
6,000 15th of 381 higher than 367 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI